Optune Gio
@optunegio.com
Optune Gio® is a wearable, portable, FDA-approved device for treating glioblastoma (GBM) in adults aged 22 or older. It is used with chemotherapy for newly diagnosed GBM following surgery, and as a standalone therapy for recurrent GBM when other treatments are no longer effective.
Optune Gio's Company Logos
Optune Gio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#385CAD
Azure
56, 92, 173
222, 51, 45
68, 47, 0, 32
#FEEBC8
Oasis
254, 235, 200
39, 96, 89
0, 7, 21, 0
#1A3D6E
Biscay
26, 61, 110
215, 62, 27
76, 45, 0, 57
About Optune Gio
Novocure's Optune Gio™ is a revolutionary FDA-approved treatment for adult patients aged 22 and older with glioblastoma (GBM), a rare and challenging form of brain cancer. Optune Gio™ creates Tumor Treating Fields (TTFields) to slow down or stop the division of GBM cancer cells. The wearable, portable device is indicated to treat newly diagnosed GBM, used alongside chemotherapy, as well as recurrent GBM. With over 25,000 users, Optune Gio™ has proven to be a powerful tool in the fight against GBM.
MyNovocure™ provides support throughout the treatment journey, offering expertise in reimbursement assistance, device setup, product education, and troubleshooting.
It's important to note that Optune Gio™ is not suitable for everyone, and should only be used after receiving training from qualified personnel. Side effects, while generally manageable, can include scalp irritation, headache, and other rare symptoms.
By redefining what it means to live with GBM, Novocure's Optune Gio™ is providing hope and extended quality of life for those battling this challenging disease.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
